Penile squamous cell carcinoma (PSCC) is a rare cancer, with approximately 2000 new
cases in the United States and 35,000 globally every year. Multiple risk factors are involved …

Objective To report contemporary treatment outcomes of penile squamous cell carcinoma at
a UK supraregional center, including patterns of therapy, oncologic results, and long-term …

Penile Squamous Cell Carcinoma: Penis-Preserving Treatment W... : Dermatologic Surgery
Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic …

Failure of response to treatment or recurrent disease is often noted in patients with penile
intraepithelial neoplasia. Photodynamic therapy has recently been added to the list of …

Background Penile cancer (PC) is a rare cancer in western countries, but is more common in
parts of the developing world. Due to its rarity and the consequent lack of randomized trials …

Of all cancers affecting the penis> 95% are squamous cell carcinoma (SCC). The disease is
rare, representing only 1% of male cancers, and incidence rates vary across the world. The …

Objectives To evaluate recurrence after penile‐sparing surgery (PSS) in the management of
carcinoma in situ (CIS) of the penis in a large multicentre cohort of patients. Patients and …

Penile cancer is a rare condition, which mostly affects men in their sixth decade of life. The
most common histology is squamous cell carcinoma (SCC), with about half of the cases …

Penile cancer at its various stages constitutes a therapeutic challenge. Management should
be increasingly confined to high volumes centres of excellence, allowing for clinical trials …

BACKGROUND: In contrast to vulvar squamous cell carcinoma (SCC), the etiologic factors
and precancerous lesions associated with penile carcinoma remain uncertain …